Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference3%

- Check28 days agoChange Detected- Page revision updated from v3.0.2 to v3.1.0. - Indicates a new software release/version of the page, with no other substantive content changes evident.SummaryDifference0.1%

- Check42 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2, and removed the 'Back to Top' element.SummaryDifference0.2%

- Check49 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check56 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as updates related to Hodgkins lymphoma and pembrolizumab. Notably, previous mentions of Hodgkin Lymphoma and related terms have been removed.SummaryDifference2%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.